Claar Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Claar Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,000	Closed	-$4.78M	–	31
2023 Q4	$4.78M	Hold	9,000	–	–	1.7%	20
2023 Q3	$4.56M	Hold	9,000	–	–	1.81%	19
2023 Q2	$4.7M	Hold	9,000	–	–	1.78%	21
2023 Q1	$5.19M	Hold	9,000	–	–	2.11%	18
2022 Q4	$4.96M	Hold	9,000	–	–	2.18%	17
2022 Q3	$4.57M	Hold	9,000	–	–	1.94%	20
2022 Q2	$4.89M	Hold	9,000	–	–	1.91%	19
2022 Q1	$5.32M	Hold	9,000	–	–	1.56%	23
2021 Q4	$6M	Hold	9,000	–	–	1.72%	21
2021 Q3	$5.14M	Hold	9,000	–	–	1.52%	25
2021 Q2	$4.54M	Hold	9,000	–	–	1.35%	26
2021 Q1	$4.11M	Hold	9,000	–	–	1.43%	23
2020 Q4	$4.19M	Buy	+9,000	New	+$4.22M	1.52%	20

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Claar Advisors's TMO Position: Q1 2024 in Review

Claar Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 9,000 shares — an estimated $4.78M sold.

Claar Advisors first reported a position in TMO in Q4 2020 and held it in 13 quarters. The position peaked at $6M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

Claar Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
Claar Advisors sold 9,000 Thermo Fisher Scientific shares in Q1 2024, an estimated $4.78M.
Claar Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 13 quarters.
Claar Advisors's Thermo Fisher Scientific position peaked at $6M in Q4 2021.
2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Claar Advisors's 13F filing for Q1 2024, filed 15 May 2024.